EGFR and lung carcinoma: Consequently, the phytochemicals CBDA, CBD, THCV, Δ-9-THC, Δ-8-THC, CBL, THCA, BCP, and γ-Ele discussed in this study could be employed as structural keys for the development of new drugs that act as EGFR-TKIs for breast and lung cancer.